Guru Ownership Trend
Guru Analysis for Genmab A/S (GMAB)
Genmab A/S (GMAB), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $123.01 M.
Top institutional holders include Renaissance Technologies (RenTech) and Louis Moore Bacon.
Institutional sentiment is currently Bullish. This is evidenced by a $30.44 M net inflow during the quarter.
Recent activity highlights Louis Moore Bacon who opened a new position. Conversely, Manning & Napier Group reduced exposure by 25.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Genmab A/S (GMAB)
Major holders include Renaissance Technologies (RenTech) ($118.44 M), Louis Moore Bacon ($5.68 M), Cliff Asness ($2.23 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 4.71 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $30.44 M, with 3 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited GMAB. The total reported sell value was $465.
Yes, 1 managers opened new positions in GMAB, and 2 increased their existing holdings. The total reported buy value was $30.44 M.